Literature DB >> 22368690

A case of idiopathic hypertrophic cranial pachymeningitis presenting high values of matrix metalloproteinase.

Kiyotaka Nakamagoe1, Ai Hosaka, Yuzuru Kondo, Eiichi Ishikawa, Akira Tamaoka.   

Abstract

This report concerns a 53-year-old male patient with idiopathic hypertrophic cranial pachymeningitis who presented with multiple cranial nerve palsies (I, II, III, IV, V, VI). Brain magnetic resonance imaging showed diffuse thickening and gadolinium enhancement of the cerebral dura mater. A biopsy of the cerebral dura mater showed granulomatous vasculitis with histiocyte infiltration. Although both the serum rheumatoid factor (RF) and matrix metalloproteinase-3 (MMP-3) were high, the patient showed no signs of arthritis. He was anti-cyclic citrullinated peptide antibody negative, which makes the presence of comorbid chronic rheumatoid arthritis (RA) unlikely. The aetiology of the pachymeningitis was unknown, which led to the diagnosis of idiopathic hypertrophic cranial pachymeningitis. Steroid pulse therapy successfully diminished the patient's pachymeningitis and lowered both RF and MMP-3. High values of RF suggest the possible involvement of an autoimmune mechanism, and the MMP value may be an important indicator of the aetiology of pachymeningitis with granulomatous vasculitis.

Entities:  

Year:  2010        PMID: 22368690      PMCID: PMC3027825          DOI: 10.1136/bcr.06.2009.2016

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  19 in total

1.  Pachymeningitis with a perinuclear antineutrophil cytoplasmic antibody: response to pulse steroid.

Authors:  K Takahashi; S Kobayashi; K Okada; S Yamaguchi
Journal:  Neurology       Date:  1998-04       Impact factor: 9.910

2.  The diagnostic properties of rheumatoid arthritis antibodies recognizing a cyclic citrullinated peptide.

Authors:  G A Schellekens; H Visser; B A de Jong; F H van den Hoogen; J M Hazes; F C Breedveld; W J van Venrooij
Journal:  Arthritis Rheum       Date:  2000-01

3.  Acute pachymeningitis mimicking subdural hematoma in a patient with polyarteritis nodosa.

Authors:  Jung-Soo Song; Myung-Kwan Lim; Bo-Hyoung Park; Won Park
Journal:  Rheumatol Int       Date:  2005-07-06       Impact factor: 2.631

4.  Meningeal sarcoidosis, pseudo-meningioma, and pachymeningitis of the convexity.

Authors:  D Ranoux; B Devaux; C Lamy; J Y Mear; F X Roux; J L Mas
Journal:  J Neurol Neurosurg Psychiatry       Date:  1992-04       Impact factor: 10.154

5.  Circulating matrix metalloproteinases and their inhibitors in patients with Kawasaki disease.

Authors:  H Senzaki; S Masutani; J Kobayashi; T Kobayashi; H Nakano; H Nagasaka; N Sasaki; H Asano; S Kyo; Y Yokote
Journal:  Circulation       Date:  2001-08-21       Impact factor: 29.690

Review 6.  Idiopathic hypertrophic pachymeningitis.

Authors:  M J Kupersmith; V Martin; G Heller; A Shah; H J Mitnick
Journal:  Neurology       Date:  2004-03-09       Impact factor: 9.910

Review 7.  Hypertrophic cranial pachymeningitis causing progressive unilateral blindness: MR findings.

Authors:  S Shintani; T Shiigai; S Tsuruoka
Journal:  Clin Neurol Neurosurg       Date:  1993-03       Impact factor: 1.876

8.  Idiopathic hypertrophic pachymeningitis.

Authors:  Shigeo Riku; Shigenori Kato
Journal:  Neuropathology       Date:  2003-12       Impact factor: 1.906

Review 9.  Two cases of hypertrophic pachymeningitis associated with myeloperoxidase antineutrophil cytoplasmic autoantibody (MPO-ANCA)-positive pulmonary silicosis in tunnel workers.

Authors:  Takako Saeki; Nobuya Fujita; Hiroyo Kourakata; Hajime Yamazaki; Syoji Miyamura
Journal:  Clin Rheumatol       Date:  2003-12-13       Impact factor: 2.980

10.  [Clinical usefulness of thallium-201 single-photon emission CT in the patient with hypertrophic cranial pachymeningitis].

Authors:  Masahiro Suzuki; Reiji Koide; Yasuhiro Kagamihara; Akira Yagishita; Hideaki Hayashi
Journal:  No To Shinkei       Date:  2004-01
View more
  1 in total

1.  Hypertrophic pachymeningitis.

Authors:  Tomasz Dziedzic; Jakub Wojciechowski; Arkadiusz Nowak; Andrzej Marchel
Journal:  Childs Nerv Syst       Date:  2015-03-15       Impact factor: 1.475

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.